These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 27177234)

  • 21. Berberine and its derivatives: a patent review (2009 - 2012).
    Singh IP; Mahajan S
    Expert Opin Ther Pat; 2013 Feb; 23(2):215-31. PubMed ID: 23231038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018).
    Nocentini A; Supuran CT; Winum JY
    Expert Opin Ther Pat; 2018 Jun; 28(6):493-504. PubMed ID: 29727210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Piperazine skeleton in the structural modification of natural products: a review.
    Zhang RH; Guo HY; Deng H; Li J; Quan ZS
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1165-1197. PubMed ID: 34080510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2014 Feb; 24(2):201-16. PubMed ID: 24215328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets.
    Sharma A; Wakode S; Fayaz F; Khasimbi S; Pottoo FH; Kaur A
    Curr Pharm Des; 2020; 26(35):4373-4385. PubMed ID: 32303168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in the synthesis of piperazine based ligands and metal complexes and their applications.
    Kant R; Maji S
    Dalton Trans; 2021 Jan; 50(3):785-800. PubMed ID: 33416816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fruitful decade from 2005 to 2014 for anthraquinone patents.
    Hussain H; Al-Harrasi A; Al-Rawahi A; Green IR; Csuk R; Ahmed I; Shah A; Abbas G; Rehman NU; Ullah R
    Expert Opin Ther Pat; 2015; 25(9):1053-64. PubMed ID: 26036306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents.
    Arnatt CK; Adams JL; Zhang Z; Haney KM; Li G; Zhang Y
    Bioorg Med Chem Lett; 2014 May; 24(10):2319-23. PubMed ID: 24731275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2016; 26(2):149-73. PubMed ID: 26561198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current trends of benzothiazoles in drug discovery: a patent review (2015-2020).
    Law CSW; Yeong KY
    Expert Opin Ther Pat; 2022 Mar; 32(3):299-315. PubMed ID: 34986720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives.
    Faizan M; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Kumar A; Chaitanya MVNL
    Med Chem; 2024; 20(8):753-780. PubMed ID: 38685782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A patent review of two fruitful decades (1997-2016) of Isocoumarin research.
    Hussain H; Green IR
    Expert Opin Ther Pat; 2017 Nov; 27(11):1267-1275. PubMed ID: 28621561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The medicinal chemistry of piperazines: A review.
    Faizan M; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Kumar A; Chaitanya MVNL
    Chem Biol Drug Des; 2024 Jun; 103(6):e14537. PubMed ID: 38888058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coumarin-based drugs: a patent review (2008 -- present).
    Kontogiorgis C; Detsi A; Hadjipavlou-Litina D
    Expert Opin Ther Pat; 2012 Apr; 22(4):437-54. PubMed ID: 22475457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.
    Wang T; Kadow JF; Zhang Z; Yin Z; Gao Q; Wu D; Parker DD; Yang Z; Zadjura L; Robinson BA; Gong YF; Spicer TP; Blair WS; Shi PY; Yamanaka G; Lin PF; Meanwell NA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5140-5. PubMed ID: 19664921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on benzofuran inhibitors: a patent review.
    Dawood KM
    Expert Opin Ther Pat; 2019 Nov; 29(11):841-870. PubMed ID: 31560232
    [No Abstract]   [Full Text] [Related]  

  • 37. A patent review of the therapeutic potential of isoflavones (2012-2016).
    Hussain H; Green IR
    Expert Opin Ther Pat; 2017 Oct; 27(10):1135-1146. PubMed ID: 28586284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).
    Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L
    Expert Opin Ther Pat; 2015 Mar; 25(3):351-66. PubMed ID: 25598152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrazine derivatives: a patent review (June 2012 - present).
    Dolezal M; Zitko J
    Expert Opin Ther Pat; 2015 Jan; 25(1):33-47. PubMed ID: 25523365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An updated patent review of therapeutic applications of chalcone derivatives (2014-present).
    Kar Mahapatra D; Asati V; Bharti SK
    Expert Opin Ther Pat; 2019 May; 29(5):385-406. PubMed ID: 31030616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.